Efficacy and other milestones for human papillomavirus vaccine introduction

Vaccine

Volumn 23, Issue 5, 2004, Pages 569-578

  Pagliusi, Sonia R ^a   Aguado, M Teresa ^a  

^a Initiative for Vaccine Research   (Switzerland)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus; Vaccine efficacy

Indexed keywords

CANCER VACCINE; HEPATITIS B VACCINE; UNCLASSIFIED DRUG; VIRUS CAPSID ANTIGEN; VIRUS DNA; VIRUS VACCINE; WART VIRUS VACCINE;

BIOPSY; CANCER EPIDEMIOLOGY; CLINICAL TRIAL; DRUG EFFICACY; EUROPE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEPATITIS B; HUMAN; INFECTION RATE; LICENSING; LIVER CANCER; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; VACCINE PRODUCTION; VIRUS DETECTION; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS;

EID: 8144220311     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.07.046     Document Type: Conference Paper

References (24)

1. World Health Report 2004: Changing History. Statistical annex. World Health Organization, http://www.who.int/whr/2004/en/index.htm.
2. A. Miller, R. Sankaranarayanan, X. Bosch, and C. Sepulveda Can screening for cervical cancer be improved, especially in developing countries? Int. J. Cancer. 107 2003 337 340
3. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J. Pathol. 189 1999 12 19
4. IARC Monographs on the evaluation of carcinogenic risks to humans: Human Papillomaviruses, vol. 64. International Agency for Research on Cancer Press; 1995.
5. H. zur Hausen Papillomaviruses and cancer: from basic studies to clinical application Nat. Rev. Cancer 2 2002 342 350
6. G.M. Clifford, J.S. Smith, M. Plummer, N. Munoz, and S. Franceschi Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis Br. J. Cancer. 88 2003 63 73
7. L.A. Koutsky, D.A. Galloway, and K.K. Holmes Epidemiology of genital human papillomavirus infection Epidemiol. Rev. 10 1988 122 163
8. X. Bosch, and S. de Sanjose Human papillomavirus and cervical cancer - burden and assessment of causality Nat. Cancer Inst. Monographs 31 2003 3 13
9. J. Schiller Papillomavirus-like particle vaccines for cervical cancer Mol. Med. Today 5 1999 209 215
10. C.D. Harro, Y.Y. Pang, R.B. Roden, A. Hildesheim, Z. Wang, and M.J. Reynolds Safety and immunogenicity trial in adult volunteers of a human Papillomavirus 16 L1 virus-like particle vaccine J. Natl. Cancer Inst. 93 2001 284 292
11. D.R. Brown, J.T. Bryan, J.M. Schroeder, T.S. Robinson, K.D. Fife, and C.M. Wheeler Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer J. Infect Dis. 184 2001 1183 1186
12. L.A. Koutsky, K.A. Ault, C.M. Wheeler, D.R. Brown, E. Barr, and F.B. Alvarez A controlled trial of a human papillomavirus type 16 vaccine N. Engl. J. Med. 347 2002 1645 1651
13. G.Y. Ho, R. Bierman, L. Beardsley, C.J. Chang, and R.D. Burk Natural history of cervicovaginal papillomavirus infection in young women N. Engl. J. Med. 338 1998 423 428
14. K.L. Liaw, A.G. Glass, M.M. Manos, C.E. Greer, D.R. Scott, and M. Sherman Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions J. Natl. Cancer Inst. 91 1999 954 960
15. N.F. Schlecht, R.W. Platt, E. Duarte-Franco, M.C. Costa, J.P. Sobrinho, and J.C. Prado Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia J. Natl. Cancer Inst. 95 2003 1336 1343
16. WHO National Cancer Control Programmes Policies and Managerial Guidelines. 2nd ed. World Health Organization 2002. http://whqlibdoc.who.int/hp/ 2002/9241545577.pdf.
17. A.G. Ostor Natural history of cervical intraepithelial neoplasia: a critical review Int. J. Gynecol. Pathol. 12 1993 186 192
18. P. Holowaty, A.B. Miller, T. Rohan, and T. To Natural history of dysplasia of the uterine cervix J. Natl. Cancer Inst. 91 1999 252 258
19. A.B. Moscicki, N. Hills, S. Shiboski, K. Powell, N. Jay, and E. Hanson Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females JAMA 285 2001 2995 3002
20. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1393-2.
21. N. Kiviat Natural history of cervical neoplasia: overview and update Am. J. Obstet. Gynecol. 175 1996 1099 1104
22. C.B. Woodman, S. Collins, H. Winter, A. Bailey, J. Ellis, and P. Prior Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study Lancet 357 2001 1831 1836
23. Dubin G. Development of an adjuvanted human Papillomavirus type 16/18 L1 virus like particle vaccine. EUROGIN 2003; SS 20-05:207.
24. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong Taiwan Childhood Hepatoma Study Group Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children N. Engl. J. Med. 336 1997 1855 1859